Avantor, Inc. (AVTR) has a MoatMap StockRank of 49/100 based on Quality (43/100), Value (52/100), and Momentum (40/100) factor scores. The current signal is HOLD. Avantor is a key supplier to the biopharma industry, but high leverage and ongoing customer destocking headwinds prevent it from being a high-conviction compounder at this stage.
Avantor, Inc. is a global provider of mission-critical products and services, supporting customers in the life sciences, advanced technologies, and applied materials sectors. The company benefits from its deeply embedded position in customer workflows, offering a vast portfolio of high-quality materials, equipment, and tailored services essential for research, development, and production. This indispensable role and extensive supply chain integration provide Avantor with a significant competitive moat.
| Price | $9.91 |
| Market Cap | $6.2B |
| P/E (Forward) | 11.19 |
| Price/Book | 1.15 |
| Return on Equity | -9.4% |
| Return on Invested Capital | -2.6% |
| Debt/Equity | 68.29 |
| Gross Margin | 32.1% |
| Operating Margin | 6.3% |
| Revenue Growth | 0.0% |
| Free Cash Flow | $489M |
Avantor, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).